Nasdaq has approved Canary’s application to list a staking ETF $INJ , ticker INJC—the first staking-based Injective product in the U.S. It plans to stake at least 90% of its holdings and charges an annual fee of 1.10%. After the news broke, $INJ surged to $8.44, up more than 10% in 24 hours, while $BTC held above $80,000 over the same period. Note that this is only approval to list; the S-1 hasn’t become effective yet, so shares can’t be traded for now. Only half the good news has been priced in. If staking ETFs get the green light, the altcoin ETFs waiting in line could follow suit. $INJ is the first to take the plunge. If it can’t hold $7.60, consider this rally over for now.
#ETF #Market Update
Not investment advice. DYOR.